Join to access to all OVN content. Join for Free
Empowering Oncologists for Patient-Centered Progress
diagnostic digital molecular residual disease MRD

Empowering Oncologists for Patient-Centered Progress


Share This Article



Summary

Pulse of the Oncologist survey reveals trends in cancer diagnostics, digital solutions, care barriers, and the innovations transforming oncology today.

In this episode of Labcorp Perspectives Oncology, host Dr. Rebecca Previs welcomes Dr. Brian Caveney, Labcorp’s Chief Medical and Scientific Officer, to unpack findings from the Pulse of the Oncologist report—a nationwide survey capturing the real-world perspectives of 152 oncologists across practice settings.

Together, Dr. Rebecca Previs and Brian Caveney dive into the pressing issues that shape oncology care today: the rising complexity of cancer treatment, the critical importance of diagnostic turnaround time, and how digital innovation can ease clinical workflows and reduce friction. They discuss why interpretive clarity in lab reports matters more than ever and spotlight the game-changing role of molecular residual disease (MRD) testing in monitoring and guiding patient care.

The conversation highlights practical solutions for improving access to advanced diagnostics, the emotional and financial burdens patients and providers face, and how health systems, labs, and payers must partner to drive equity and innovation.

Ready to hear what oncologists really want and what’s next for cancer care? Tune in now for essential insights that will reshape your view of the future of oncology.

Click for Source

Related Topics

Meet Our Innovation Partners

Loading partners...